Skip to main content
Top
Published in: Lung 1/2021

Open Access 01-02-2021 | AIRWAY BETA-2 ADRENERGIC RECEPTOR SIGNALING PATHWAY

Spatiotemporal Changes in the Gene Expression Spectrum of the β2 Adrenergic Receptor Signaling Pathway in the Lungs of Rhesus Monkeys

Authors: Zhongmei Zheng, Bangrong Cao, Yu Hu, Liang Xie, Ling Gu, Fang Shi, Hanmin Liu

Published in: Lung | Issue 1/2021

Login to get access

Abstract

Objective

β2 adrenergic receptor (ADRB2) agonists mainly participate in regulation of airway function through the ADRB2-G protein-adenylyl cyclase (AC) signaling pathway; however, the key genes associated with this pathway and the spatiotemporal changes in the expression spectrum of some of their subtypes remain unclear, resulting in an insufficient theoretical basis for formulating the dose and method of drug administration for neonates.

Methods

We performed sampling at different developmental time points in rhesus monkeys, including the embryo stage, neonatal stage, and adolescence. The MiSeq platform was used for sequencing of key genes and some of their subtypes in the ADRB2 signaling pathway in lung tissues, and target gene expression was normalized and calculated according to reads per kilobase million.

Results

At different lung-developmental stages, we observed expression of phenylethanolamine N-methyltransferase (PNMT), ADRB2, AC, AKAP and EPAC subtypes (except AC8, AKAP4/5), and various phosphodiesterase (PDE) subtypes (PDE3, PDE4, PDE7, and PDE8), with persistently high expression of AC6, PDE4B, and AKAP(1/2/8/9/12/13, and EZR) maintained throughout the lung-developmental process, PNMT, ADRB2, AC(4/6), PDE4B, and AKAP(1/2/8/9/12/13, EZR, and MAP2)were highly expressed at the neonatal stage.

Conclusion

During normal lung development in rhesus monkeys, key genes associated with ADRB2–G protein–AC signaling and some of their subtypes are almost all expressed at the neonatal stage, suggesting that this signaling pathway plays a role in this developmental stage. Additionally, AC6, PDE4B, and AKAP(1/2/8/9/12/13, and EZR) showed persistently high expression during the entire lung-developmental process, which provides a reference for the development and utilization of key gene subtypes in this pathway.
Literature
1.
go back to reference Armangil D, Yurdakök M, Korkmaz A, Yiğit S, Tekinalp G (2011) Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. J Pediatr 159:398–403CrossRef Armangil D, Yurdakök M, Korkmaz A, Yiğit S, Tekinalp G (2011) Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. J Pediatr 159:398–403CrossRef
2.
go back to reference Raffay T, Kc P, Reynolds J, Di Fiore J, MacFarlane P, Martin RJ (2014) Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model. Neonatology 106:126–132CrossRef Raffay T, Kc P, Reynolds J, Di Fiore J, MacFarlane P, Martin RJ (2014) Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model. Neonatology 106:126–132CrossRef
3.
go back to reference Mandell EW, Kratimenos P, Abman SH, Steinhorn RH (2019) Drugs for the prevention and treatment of bronchopulmonary dysplasia. Clin Perinatol 46:291–310CrossRef Mandell EW, Kratimenos P, Abman SH, Steinhorn RH (2019) Drugs for the prevention and treatment of bronchopulmonary dysplasia. Clin Perinatol 46:291–310CrossRef
4.
go back to reference Johnson M (2006) Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117:18–24CrossRef Johnson M (2006) Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117:18–24CrossRef
5.
go back to reference Kolinski M, Plazinska A, Jozwiak K (2012) Recent progress in understanding of structure, ligand interactions and the mechanism of activation of the β2-adrenergic receptor. Curr Med Chem 19:1155–1163CrossRef Kolinski M, Plazinska A, Jozwiak K (2012) Recent progress in understanding of structure, ligand interactions and the mechanism of activation of the β2-adrenergic receptor. Curr Med Chem 19:1155–1163CrossRef
6.
go back to reference Xu D, Isaacs C, Hall IP, Emala CW (2001) Human airway smooth muscle expresses 7 isoforms of adenylyl cyclase: a dominant role for isoform V. Am J Physiol Lung Cell Mol Physiol 281:832–843CrossRef Xu D, Isaacs C, Hall IP, Emala CW (2001) Human airway smooth muscle expresses 7 isoforms of adenylyl cyclase: a dominant role for isoform V. Am J Physiol Lung Cell Mol Physiol 281:832–843CrossRef
7.
go back to reference Chen Y, Huang G, Wang Y, Cheng M, Zhu F, Zhong J, Gao Y (2019) Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice. Respir Res 20(1):285CrossRef Chen Y, Huang G, Wang Y, Cheng M, Zhu F, Zhong J, Gao Y (2019) Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice. Respir Res 20(1):285CrossRef
8.
go back to reference Poppinga W, Heijink I, Holtzer L, Skroblin P, Klussmann E, Halayko A, Timens W, Maarsingh H, Schmidt M (2015) A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 308(8):L766-775CrossRef Poppinga W, Heijink I, Holtzer L, Skroblin P, Klussmann E, Halayko A, Timens W, Maarsingh H, Schmidt M (2015) A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 308(8):L766-775CrossRef
9.
go back to reference Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, Luo P (2018) Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap. Drug Des Devel Ther 12:2371–2379CrossRef Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, Luo P (2018) Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap. Drug Des Devel Ther 12:2371–2379CrossRef
10.
go back to reference Johnstone TB, Smith KH, Koziol-White CJ, Li F, Kazarian AG, Corpuz ML, Shumyatcher M, Ehlert FJ, Himes BE, Panettieri RA, Ostrom RS (2018) PDE8 is expressed in human airway smooth muscle and selectively regulates cAMP signaling by β-adrenergic receptors and adenylyl cyclase 6. Am J Respir Cell Mol Biol 58:530–541CrossRef Johnstone TB, Smith KH, Koziol-White CJ, Li F, Kazarian AG, Corpuz ML, Shumyatcher M, Ehlert FJ, Himes BE, Panettieri RA, Ostrom RS (2018) PDE8 is expressed in human airway smooth muscle and selectively regulates cAMP signaling by β-adrenergic receptors and adenylyl cyclase 6. Am J Respir Cell Mol Biol 58:530–541CrossRef
11.
go back to reference Hütten MC, Fehrholz M, Konrad FM, Ophelders D, Kleintjes C, Ottensmeier B, Spiller OB, Glaser K, Kramer BW, Kunzmann S (2019) Detrimenta effects of an inhaled phosphodiesterase-4 inhibitor on lung inflammation in ventilated preterm lambs exposed to chorioamnionitis are dose dependent. J Aerosol Med Pulm Drug Deliv 32:396–404CrossRef Hütten MC, Fehrholz M, Konrad FM, Ophelders D, Kleintjes C, Ottensmeier B, Spiller OB, Glaser K, Kramer BW, Kunzmann S (2019) Detrimenta effects of an inhaled phosphodiesterase-4 inhibitor on lung inflammation in ventilated preterm lambs exposed to chorioamnionitis are dose dependent. J Aerosol Med Pulm Drug Deliv 32:396–404CrossRef
12.
go back to reference Zuo H, Han B, Poppinga W, Ringnalda L, Kistemaker L, Halayko A, Gosens R, Nikolaev V, Schmidt M (2018) Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells. Br J Pharmacol 175(14):2988–3006CrossRef Zuo H, Han B, Poppinga W, Ringnalda L, Kistemaker L, Halayko A, Gosens R, Nikolaev V, Schmidt M (2018) Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells. Br J Pharmacol 175(14):2988–3006CrossRef
13.
go back to reference Xu J, Feng L, Han Z, Li Y, Wu A, Shao T, Ding N, Li L, Deng W, Di X, Wang J, Zhang L, Li X, Zhang K, Cheng S (2016) Extensive ceRNA-ceRNA interaction networks mediated by miRNAs regulate development in multiple rhesus tissues. Nucleic Acids Res 44:9438–9451CrossRef Xu J, Feng L, Han Z, Li Y, Wu A, Shao T, Ding N, Li L, Deng W, Di X, Wang J, Zhang L, Li X, Zhang K, Cheng S (2016) Extensive ceRNA-ceRNA interaction networks mediated by miRNAs regulate development in multiple rhesus tissues. Nucleic Acids Res 44:9438–9451CrossRef
14.
go back to reference Yu X, Feng L, Han Z, Wu B, Wang S, Xiao Y, Li F, Zhang L, Cao B, Di X, Lu D, Li X, Jiang W, Zhang K, Cheng S (2016) Crosstalk of dynamic functional modules in lung development of rhesus macaques. Mol Biosyst 12:1342–1349CrossRef Yu X, Feng L, Han Z, Wu B, Wang S, Xiao Y, Li F, Zhang L, Cao B, Di X, Lu D, Li X, Jiang W, Zhang K, Cheng S (2016) Crosstalk of dynamic functional modules in lung development of rhesus macaques. Mol Biosyst 12:1342–1349CrossRef
15.
go back to reference Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, Browne W, Clark A, Cuthill I, Dirnagl U et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410CrossRef Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, Browne W, Clark A, Cuthill I, Dirnagl U et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410CrossRef
16.
go back to reference Sio YY, Matta SA, Ng YT, Chew FT (2020) Epistasis between phenylethanolamine N-methyltransferase and β2-adrenergic receptor influences extracellular epinephrine level and associates with the susceptibility to allergic asthma. Clin Exp Allergy 50:352–363CrossRef Sio YY, Matta SA, Ng YT, Chew FT (2020) Epistasis between phenylethanolamine N-methyltransferase and β2-adrenergic receptor influences extracellular epinephrine level and associates with the susceptibility to allergic asthma. Clin Exp Allergy 50:352–363CrossRef
17.
go back to reference Kennedy B, Bigby TD, Ziegler MG (1995) Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J Clin Invest 95:2896–2902CrossRef Kennedy B, Bigby TD, Ziegler MG (1995) Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J Clin Invest 95:2896–2902CrossRef
18.
go back to reference Stratton CF, Poulin MB, Du Q, Schramm VL (2017) Kinetic isotope effects and transition state structure for human phenylethanolamine N-methyltransferase. ACS Chem Biol 12:342–346CrossRef Stratton CF, Poulin MB, Du Q, Schramm VL (2017) Kinetic isotope effects and transition state structure for human phenylethanolamine N-methyltransferase. ACS Chem Biol 12:342–346CrossRef
19.
go back to reference Reinhardt D (1989) Adrenoceptors and the lung: their role in health and disease. Eur J Pediatr 148:286–293CrossRef Reinhardt D (1989) Adrenoceptors and the lung: their role in health and disease. Eur J Pediatr 148:286–293CrossRef
20.
go back to reference Hislop AA, Mak JC, Kelly D, Reader JA, Barnes PJ, Haworth SG (2002) Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn. Br J Pharmacol 135:1415–1424CrossRef Hislop AA, Mak JC, Kelly D, Reader JA, Barnes PJ, Haworth SG (2002) Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn. Br J Pharmacol 135:1415–1424CrossRef
21.
go back to reference Hirshman CA, Zhu D, Panettieri RA, Emala CW (2001) Actin depolymerization via the beta-adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway. Am J Physiol Cell Physiol 281(5):C1468-1476CrossRef Hirshman CA, Zhu D, Panettieri RA, Emala CW (2001) Actin depolymerization via the beta-adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway. Am J Physiol Cell Physiol 281(5):C1468-1476CrossRef
22.
go back to reference Bogard AS, Xu C, Ostrom RS (2011) Human bronchial smooth muscle cells express adenylyl cyclase isoforms 2, 4, and 6 in distinct membrane microdomains. J Pharmacol Exp Ther 337:209–217CrossRef Bogard AS, Xu C, Ostrom RS (2011) Human bronchial smooth muscle cells express adenylyl cyclase isoforms 2, 4, and 6 in distinct membrane microdomains. J Pharmacol Exp Ther 337:209–217CrossRef
23.
go back to reference Agarwal SR, Fiore C, Miyashiro K, Ostrom RS, Harvey RD (2019) β effect of adenylyl cyclase type 6 on localized production of cAMP by -2 adrenoceptors in human airway smooth-muscle cells. J Pharmacol Exp Ther 370:104–110CrossRef Agarwal SR, Fiore C, Miyashiro K, Ostrom RS, Harvey RD (2019) β effect of adenylyl cyclase type 6 on localized production of cAMP by -2 adrenoceptors in human airway smooth-muscle cells. J Pharmacol Exp Ther 370:104–110CrossRef
24.
go back to reference Matera M, Page C, Cazzola M (2014) PDE inhibitors currently in early clinical trials for the treatment of asthma. Expert Opin Investig Drugs 23(9):1267–1275CrossRef Matera M, Page C, Cazzola M (2014) PDE inhibitors currently in early clinical trials for the treatment of asthma. Expert Opin Investig Drugs 23(9):1267–1275CrossRef
25.
go back to reference Billington C, Ojo O, Penn R, Ito S (2013) cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther 26(1):112–120CrossRef Billington C, Ojo O, Penn R, Ito S (2013) cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther 26(1):112–120CrossRef
26.
go back to reference Schudt C, Gantner F, Tenors H, Hatzelmann A (1999) Therapeutic potential of selective PDE inhibitors in asthma. Pulm Pharmacol Ther 12(2):123–129CrossRef Schudt C, Gantner F, Tenors H, Hatzelmann A (1999) Therapeutic potential of selective PDE inhibitors in asthma. Pulm Pharmacol Ther 12(2):123–129CrossRef
27.
go back to reference Beute J, Ganesh K, Nastiti H, Hoogenboom R, Bos V, Folkerts J, Schreurs M, Hockman S, Hendriks R, KleinJan A (2020) PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells. Front Pharmacol 11:470CrossRef Beute J, Ganesh K, Nastiti H, Hoogenboom R, Bos V, Folkerts J, Schreurs M, Hockman S, Hendriks R, KleinJan A (2020) PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells. Front Pharmacol 11:470CrossRef
28.
go back to reference Yick C, Zwinderman A, Kunst P, Grünberg K, Mauad T, Dijkhuis A, Bel E, Baas F, Lutter R, Sterk P (2013) Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: asthma versus controls. Eur Respir J 42(3):662–670CrossRef Yick C, Zwinderman A, Kunst P, Grünberg K, Mauad T, Dijkhuis A, Bel E, Baas F, Lutter R, Sterk P (2013) Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: asthma versus controls. Eur Respir J 42(3):662–670CrossRef
29.
go back to reference Matera M, Page C, Calzetta L, Rogliani P, Cazzola M (2020) Pharmacology and therapeutics of bronchodilators revisited. Pharmacol Rev 72(1):218–252CrossRef Matera M, Page C, Calzetta L, Rogliani P, Cazzola M (2020) Pharmacology and therapeutics of bronchodilators revisited. Pharmacol Rev 72(1):218–252CrossRef
30.
go back to reference Calzetta L, Page C, Spina D, Cazzola M, Rogliani P, Facciolo F, Matera M (2013) Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. J Pharmacol Exp Ther 346(3):414–423CrossRef Calzetta L, Page C, Spina D, Cazzola M, Rogliani P, Facciolo F, Matera M (2013) Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. J Pharmacol Exp Ther 346(3):414–423CrossRef
31.
go back to reference Spina D (2003) Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Drugs 63(23):2575–2594CrossRef Spina D (2003) Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. Drugs 63(23):2575–2594CrossRef
32.
go back to reference Shepherd M (2006) Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors. Pulm Pharmacol Ther 19(1):24–31CrossRef Shepherd M (2006) Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors. Pulm Pharmacol Ther 19(1):24–31CrossRef
33.
go back to reference Cazzola M, Calzetta L, Rogliani P, Matera M (2019) Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs 28(10):827–833CrossRef Cazzola M, Calzetta L, Rogliani P, Matera M (2019) Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs 28(10):827–833CrossRef
34.
go back to reference Patel BS, Prabhala P, Oliver BG, Ammit AJ (2015) Inhibitors of phosphodiesterase 4, but not phosphodiesterase 3, increase β2-agonist-induced expression of antiinflammatory mitogen-activated protein kinase phosphatase 1 in airway smooth muscle cells. Am J Respir Cell Mol Biol 52:634–640CrossRef Patel BS, Prabhala P, Oliver BG, Ammit AJ (2015) Inhibitors of phosphodiesterase 4, but not phosphodiesterase 3, increase β2-agonist-induced expression of antiinflammatory mitogen-activated protein kinase phosphatase 1 in airway smooth muscle cells. Am J Respir Cell Mol Biol 52:634–640CrossRef
35.
go back to reference Konrad FM, Bury A, Schick MA, Ngamsri KC, Reutershan J (2015) The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation. PLoS ONE 10:e0121725CrossRef Konrad FM, Bury A, Schick MA, Ngamsri KC, Reutershan J (2015) The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation. PLoS ONE 10:e0121725CrossRef
36.
go back to reference Beghè B, Rabe K, Fabbri L (2013) Phosphodiesterase-4 inhibitor therapy for lung diseases. Am J Respir Crit Care Med 188(3):271–278CrossRef Beghè B, Rabe K, Fabbri L (2013) Phosphodiesterase-4 inhibitor therapy for lung diseases. Am J Respir Crit Care Med 188(3):271–278CrossRef
37.
go back to reference Gaurav A, Gautam V (2017) Pharmacophore based virtual screening approach to identify selective PDE4B inhibitors. Iran J Pharm Res 16(3):910–923PubMedPubMedCentral Gaurav A, Gautam V (2017) Pharmacophore based virtual screening approach to identify selective PDE4B inhibitors. Iran J Pharm Res 16(3):910–923PubMedPubMedCentral
38.
go back to reference Thompson M, Britt R, Kuipers I, Stewart A, Thu J, Pandya H, MacFarlane P, Pabelick C, Martin R, Prakash Y (2015) cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle. Biochim Biophys Acta 1853:2506–2514CrossRef Thompson M, Britt R, Kuipers I, Stewart A, Thu J, Pandya H, MacFarlane P, Pabelick C, Martin R, Prakash Y (2015) cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle. Biochim Biophys Acta 1853:2506–2514CrossRef
39.
go back to reference Horvat S, Deshpande D, Yan H, Panettieri R, Codina J, DuBose T, Xin W, Rich T, Penn R (2012) A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle. FASEB J 26(9):3670–3679CrossRef Horvat S, Deshpande D, Yan H, Panettieri R, Codina J, DuBose T, Xin W, Rich T, Penn R (2012) A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle. FASEB J 26(9):3670–3679CrossRef
40.
go back to reference Yin L, Duan T, Ulloa L, Yang Y (2018) Ezrin orchestrates signal transduction in airway cells. Rev Physiol Biochem Pharmacol 174:1–23PubMedPubMedCentral Yin L, Duan T, Ulloa L, Yang Y (2018) Ezrin orchestrates signal transduction in airway cells. Rev Physiol Biochem Pharmacol 174:1–23PubMedPubMedCentral
Metadata
Title
Spatiotemporal Changes in the Gene Expression Spectrum of the β2 Adrenergic Receptor Signaling Pathway in the Lungs of Rhesus Monkeys
Authors
Zhongmei Zheng
Bangrong Cao
Yu Hu
Liang Xie
Ling Gu
Fang Shi
Hanmin Liu
Publication date
01-02-2021
Publisher
Springer US
Published in
Lung / Issue 1/2021
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-021-00420-2

Other articles of this Issue 1/2021

Lung 1/2021 Go to the issue

VAPING AND NONTUBERCULOUS MYCOBACTERIAL INFECTION

Vaping Associated Pulmonary Nontuberculous Mycobacteria

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.